FDA: Center for Biologics Evaluation and Research

FDA: CENTER FOR BIOLOGICS EVALUATION AND RESEARCH (CBER)

Contract titled “Comprehensive Linked Data Collectionof Biologic Pharmaceuticals and Medical Events.” 2002 – 2005 Principal Investigator
Biologics used in the treatment of rheumatoid arthritis and Crohn's Disease. 2002 - 2005 in collaboration with The University of Alabama, Birmingham ($409,998 award)
Evaluating the impact of AAP/PHS 1999 joint recommendation to delay newborn Hepatitis B
vaccination ($179,400 award)
Study of adverse events associated with prolonged antibiotic use. 2003 – 2005 with the FDA Office of Counterterrorism ($499,145 award)
Evaluating adverse events associated with recipients\ of tissue transplants ($110,000 award)